BIOMAT Database Logo BIOMAT Database Logo

Confusing bacterial endocarditis recommendations. 1991

J R Schlicht, and A M Stablein, and G J Vanscoy

UI MeSH Term Description Entries
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D004697 Endocarditis, Bacterial Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use. Bacterial Endocarditides,Bacterial Endocarditis,Endocarditides, Bacterial
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012958 Societies, Scientific Societies whose membership is limited to scientists. Scientific Societies,American Psychological Association,Scientific Society,Society, Scientific

Related Publications

J R Schlicht, and A M Stablein, and G J Vanscoy
Comment: bacterial endocarditis recommendations.
May 1992, The Annals of pharmacotherapy,
J R Schlicht, and A M Stablein, and G J Vanscoy
Prevention of bacterial endocarditis: current recommendations.
August 1987, Journal of the Mississippi State Medical Association,
J R Schlicht, and A M Stablein, and G J Vanscoy
[Prevention of bacterial endocarditis: current recommendations].
April 1993, Revue medicale de Bruxelles,
J R Schlicht, and A M Stablein, and G J Vanscoy
Drugs in dentistry. Bacterial endocarditis: new recommendations.
January 1985, Dental management,
J R Schlicht, and A M Stablein, and G J Vanscoy
Prevention of bacterial endocarditis: American Heart Association recommendations.
October 1997, JAMA,
J R Schlicht, and A M Stablein, and G J Vanscoy
Revised recommendations for the prevention of bacterial endocarditis.
November 1991, The Nebraska medical journal,
J R Schlicht, and A M Stablein, and G J Vanscoy
New recommendations for antibiotic prophylaxis of bacterial endocarditis.
March 1985, American journal of diseases of children (1960),
J R Schlicht, and A M Stablein, and G J Vanscoy
New recommendations for the prevention of bacterial endocarditis.
February 1991, Journal of the Medical Association of Georgia,
J R Schlicht, and A M Stablein, and G J Vanscoy
Prevention of bacterial endocarditis: American Heart Association recommendations.
October 1997, JAMA,
J R Schlicht, and A M Stablein, and G J Vanscoy
Prevention of bacterial endocarditis: American Heart Association recommendations.
October 1997, JAMA,
Copied contents to your clipboard!